Trial Profile
To assess efficacy of immunocryosurgery (Cryosurgery during Imiquimod)for the treatment of Periocular Basal Cell Carcinomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 17 Feb 2017 New trial record